FDA Orange Book · active-ingredient family
Beclomethasone dipropionate monohydrate
Beclomethasone dipropionate monohydrate is approved in 3 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:BECONASE AQ · NDA 019389
3
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · spray, metered
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| BECONASE AQRLD | GLAXOSMITHKLINE | NDA 019389 | — | Jul 27, 1987 | |
| VANCENASE AQ | SCHERING | NDA 020469 | — | Jun 26, 1996 | |
| VANCENASE AQ | SCHERING | NDA 019589 | — | Dec 23, 1987 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Beclomethasone dipropionate monohydrate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

